Azacytidine During Anti-tuberculosis Therapy

Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Azacitidine Injection [Vidaza] - Phase A Group;   Drug: Azacitidine Injection [Vidaza] - Phase B Group;   Drug: Azacitidine Injection [Vidaza] - Phase C Group;   Drug: Azacitidine Injection [Vidaza] - Phase D Group Sponsors:   Andrew Dinardo;   Celgene Corporation Not yet recruiting

Source: ClinicalTrials.gov - May 8, 2019 Category: Research Source Type: clinical trials